ALTURiX Sold to Kelso Pharma in Strategic Move

Deal News | Mar 11, 2025 | Farrer & Co

ALTURiX Sold to Kelso Pharma in Strategic Move

The shareholders of ALTURiX Holdings Limited have agreed to sell the company to Kelso Pharma, under the guidance of legal advisory firm Farrer & Co. ALTURiX, based in Milton Keynes, focuses on providing branded specialty medicines, enhancing patient care, and alleviating NHS costs. Kelso Pharma, backed by Apposite Capital, specializes in innovative medicines for Europe. The transaction was managed by Tom Bruce and his corporate team from Farrer & Co, emphasizing a collaborative and well-aligned process. The co-founders expressed satisfaction with the meticulous representation and teamwork that facilitated the sale. The acquisition aligns strategically with Kelso Pharma's growth goals, promising advancements for patients and healthcare providers.

Sectors

  • Pharmaceutical Industry
  • Healthcare Investments
  • Legal Advisory

Geography

  • United Kingdom – ALTURiX is based in Milton Keynes, Kelso Pharma is UK-headquartered, and the advisory firm Farrer & Co is also located in the UK.
  • Europe – The acquisition focuses on expanding the presence of Kelso Pharma in the European healthcare markets.

Industry

  • Pharmaceutical Industry – The article involves ALTURiX and Kelso Pharma, both of which are companies in the pharmaceutical sector.
  • Healthcare Investments – Involves Apposite Capital, a fund specializing in healthcare investments, which backs Kelso Pharma.
  • Legal Advisory – Features legal advisory provided by Farrer & Co for the acquisition process.

Financials

    Participants

    NameRoleTypeDescription
    ALTURiX Holdings LimitedTarget CompanyCompanyA pharmaceutical business supplying branded specialty medicines.
    Kelso PharmaBidding CompanyCompanyA UK-headquartered pharmaceutical business focusing on bringing innovative medicines to European healthcare markets.
    Apposite CapitalInvestorCompanyA fund specializing in healthcare investments, backing Kelso Pharma.
    Farrer & CoLegal AdvisorCompanyProvided legal advisory services to the shareholders of ALTURiX during the sale process.
    Simon CloughCo-FounderPersonCo-Founder of ALTURiX, involved in the sale process.
    Lak SahotaCo-FounderPersonCo-Founder of ALTURiX, involved in the sale process.
    Simon FisherCo-FounderPersonCo-Founder of ALTURiX, comments on the company's growth and sale.
    Tom BruceHead of EntrepreneursPersonLed the Farrer & Co legal team handling the transaction.
    Georgina FraserCorporate Senior AssociatePersonPart of the Farrer & Co corporate team assisting in the sale.
    Georgia SlaterCorporate AssociatePersonPart of the Farrer & Co corporate team assisting in the sale.